Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AbbVie Inc.
  6. News
  7. Summary
    ABBV   US00287Y1091

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ABBVIE INC. : Ex-dividend day for

10/14/2021 EST

A dividend is removed today from AbbVie Inc.'s share.



ę Factset 2021
All news about ABBVIE INC.
11/24Truist Adjusts Price Target on AbbVie to $135 From $118, Maintains Buy Rating
MT
11/24NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/23AbbVie Shares Rise After Societe Generale's Upgrade, Price Target Hike
MT
11/23Societe Generale Upgrades AbbVie to Buy from Hold, Raises Price Target to $172 From $11..
MT
11/23WALL STREET STOCK EXCHANGE : The Fed cannot stop Covid
11/23AbbVie to Present at the Evercore ISI Conference
PR
11/23AbbVie to Present at the Piper Sandler Healthcare Conference
PR
11/23ANALYST RECOMMENDATIONS : AbbVie, AIG, CBRE, Stoneco, Vonage...
11/18AbbVie Expands Immunology Portfolio in the European Union with the European Commission ..
AQ
11/18AbbVie Announces First Provincial Reimbursement for VENCLEXTA« (venetoclax) with Obinut..
AQ
More news
Analyst Recommendations on ABBVIE INC.
More recommendations
Financials (USD)
Sales 2021 56 214 M - -
Net income 2021 11 451 M - -
Net Debt 2021 66 520 M - -
P/E ratio 2021 18,0x
Yield 2021 4,47%
Capitalization 206 B 206 B -
EV / Sales 2021 4,85x
EV / Sales 2022 4,33x
Nbr of Employees 50 000
Free-Float 98,0%
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | ABBV | US00287Y1091 | MarketScreener
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 116,51 $
Average target price 130,00 $
Spread / Average Target 11,6%
EPS Revisions
Managers and Directors
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman-Management Board & President
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Azita Saleki-Gerhardt Executive Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
ABBVIE INC.8.74%209 777
JOHNSON & JOHNSON1.82%421 847
ROCHE HOLDING AG17.17%334 769
PFIZER, INC.38.25%285 639
NOVO NORDISK A/S68.76%247 704
ELI LILLY AND COMPANY55.18%237 527